Journal of Traditional Chinese Medicine >
Combined acupuncture and herb treatment improves intestinal flora inabdominally obese subjects based on 16s rRNA sequencing: a randomized controlled trial
Received date: 2024-03-23
Accepted date: 2024-09-24
Online published: 2026-01-28
Supported by
National Key R&D Program of China: Clinical Evaluation Research on Intervention Technologies for Abdominal Obesity; the Role of Gut Microbiota in the Effects of Combined Acupuncture and Medication on Abdominal Obesity: an Exploration with 16S rRNA Technology(2019YFC1710102)
OBJECTIVE: To investigate Acupuncture-herb therapy modulates gut microbiota in abdominal obesity.
METHODS: A randomized controlled trial was designed in accordance with standard protocols. Abdominally obese subjects were randomized into four groups: A2 (Control): double placebo, A1 (Needle): press needle + placebo herb, A3 (herb): herbal medicine (Huatan Lishi Fang化痰利湿方) + placebo needle, A4 (Combination): press needle + herbal medicine. After 12 weeks of treatment, groups were relabeled B1-B4. Weight, waist circumference, and body mass index were measured monthly. Gut microbiota was analyzed via 16S rRNA sequencing for diversity and abundance.
RESULTS: Combined needle-herb therapy significantly reduced waist circumference (P < 0.05). All treatments altered gut microbiota composition. The combination group showed significant changes in diversity (Chao1, Shannon, Simpson; P < 0.05). Needle therapy increased Bacteroidia; herbs reduced Lachnospiraceae and Megamonas. All results were significant (P < 0.05).
CONCLUSION: Combined needle-herb treatment modulated 25 key gut flora across multiple taxonomic levels in abdominal obesity. It reduced Firmicutes and Bacteroidota. Bacteroidota, Actinobacteriota, and Prevo-tellaceae may suppress obesity, whereas Proteobacteria, Lachnospiraceae, and Megamonas may promote it. The combination specifically altered Bacteroidaceae, Lachno-spiraceae, Bacteroidia, and Megamonas.
Menghua YUAN , Jianbin SHAO , Yawei YANG , Yan ZHAO , Xingang HU . Combined acupuncture and herb treatment improves intestinal flora inabdominally obese subjects based on 16s rRNA sequencing: a randomized controlled trial[J]. Journal of Traditional Chinese Medicine, 2026 , 46(1) : 205 -210 . DOI: 10.19852/j.cnki.jtcm.2026.01.019
| 1. | Li S, Wang Y, Ying Y, et al. Independent and joint associations of BMI and waist circumference with the onset of type 2 diabetes mellitus in Chinese adults: prospective data linkage study. JMIR Public Health Surveill 2023; 9: 1-8. |
| 2. | Lin J. Clinical observation of Shenshu Heye decoction on spleen deficiency and phlegm turbidities in obese type 2 diabetes mellitus. Nanjing Zhong Yi Yao 2020; 39: 45-9. |
| 3. | Sheng J, Yang G, Jin X, et al. Electroacupuncture combined with diet treatment has a therapeutic effect on perimenopausal patients with abdominal obesity by improving the community structure of intestinal flora. Front Physiol 2021; 12: 708588. |
| 4. | Shen LY, Fu XF, Zeng Q, et al. Comparison of the efficacy of different frequency electroacupuncture in the treatment of polycystic ovary syndrome patients with abdominal obesity. Zhen Ci Yan Jiu 2023; 48: 1266-73. |
| 5. | Lambert DC, Kane J, Slaton A, et al. Associations of metabolic syndrome and abdominal obesity with anion gap metabolic acidosis among US adults. Kidney 360 2022; 6: 102-9. |
| 6. | Tian X, Chen SH, Wang PL, et al. Insulin resistance mediates obesity-related risk of cardiovascular disease: a prospective cohort study. Cardiovasc Diabetol 2022; 21: 123-6. |
| 7. | Armanmehr A, Jafari Khamirani H, Zoghi S, et al. Analysis of DYRK1B, PPARG, and CEBPB expression patterns in adipose-derived stem cells from patients carrying DYRK1B R102C and healthy individuals during adipogenesis. Metab Syndr Relat Disord 2022; 16: 89-6. |
| 8. | Wang DD, Teng ML, Wang YY, et al. GPNMB promotes abdominal fat deposition in chickens: Genetic variation, expressional profile, biological function, and transcriptional regulation. Poult Sci 2022; 11: 351-9. |
| 9. | Ma QT, Li YQ, Li PF, et al. Research progress in the relationship between type 2 diabetes mellitus and intestinal flora. Biomed Pharmacother 2019; 17: 187-3. |
| 10. | Sha D, Wang YT, Han L, et al. The intervention effect of Traditional Chinese Medicine on the intestinal flora and its metabolites in glycolipid metabolic disorders. Evid Based Complement Alternat Med 2019; 2019: 1-10. |
| 11. | Li XL, Shi WH, Xiong QH, et al. Leptin improves intestinal flora dysfunction in mice with high-fat diet-induced obesity. Yi Xue Yan Jiu 2020; 48: 1723-9. |
| 12. | Sergeev IN, Aljutaily T, Walton G, Huarte E. Effects of synbiotic supplement on human gut microbiota, body composition and weight loss in obesity. Nutrients 2020; 12: 222-30. |
| 13. | Baradaran Rahimi V, Askari VR, Hosseinzadeh H. Promising influences of Scutellaria baicalensis and its two active constituents, baicalin, and baicalein, against metabolic syndrome: a review. Phytother Res 2021; 35: 201-5. |
| 14. | Noh JW, Yang HK, Jun MS, Lee BC. Puerarin attenuates obesity-induced inflammation and dyslipidemia by regulating macro-phages and TNF-α in obese mice. Biomedicines 2022; 10: 175-3. |
| 15. | Habtemariam S. Berberine pharmacology and the gut microbiota: a hidden therapeutic link. Pharmacol Res 2020; 15: 735-2. |
| 16. | Hussain A, Yadav MK, Bose S, et al. Daesiho-tang is an effective herbal formulation in attenuation of obesity in mice through alteration of gene expression and modulation of intestinal microbiota. PLoS One 2019; 14: 1-10. |
| 17. | Huang Q, Song YJ, Yu ZM, et al. Electroacupuncture improves inflammatory reaction and insulin sensitivity in insulin-resistant obese rats. Zhen Ci Yan Jiu 2019; 44: 215-20. |
| 18. | Tong X, Xu J, Lian F, Yu X. Structural alteration of gut microbiota during the amelioration of human type 2 diabetes with hyperlipidemia by metformin and a traditional Chinese herbal formula: a multicenter, randomized, open label clinical trial. Biomedicines 2018; 9: 1-10. |
| 19. | Qi H, Rui CN, Miao P, Lun L, Tong L. Effects of electrotherapy on SIRT1/NF-κB signaling pathway in adipose tissue of obese rats. Zhong Guo Zhen Jiu 2020; 40: 895-900. |
| 20. | Tian X, Song A, Liang FX, et al. Effects of electricity on insulin resistance to energy regulatory signaling leptin in obese rats. Zhen Ci Yan Jiu 2021; 46: 321-6. |
| 21. | Koliada A, Syzenko G, Moseiko V, et al. Association between body mass index and Firmicutes/Bacteroidetes ratio in an adult Ukrainian population. BMC Microbiology 2017; 17: 120-7. |
| 22. | Nicolucci AC, Hume MP, Martínez I, et al. Prebiotics reduce body fat and alter intestinal microbiota in children who are overweight or with obesity. Gastroenterology 2017; 153: 1217-25. |
| 23. | Rosenstock J, Allison D, Birkenfeld AL, et al. Effect of additional oral semaglutide vs sitagliptin on glycated hemoglobin in adults with type 2 diabetes uncontrolled with metformin alone or with sulfonylurea: the PIONEER 3 randomized clinical trial. JAMA 2019; 321: 15-23. |
| 24. | Angelino D, Martina A, Rosi A, et al. Glucose- and lipid-related biomarkers are affected in healthy obese or hyperglycemic adults consuming a whole-grain pasta enriched in prebiotics and probiotics: a 12-week randomized controlled trial. J Nutr 2019; 149: 1807-15. |
| 25. | Li SC, Hsu WF, Chang JS, Shih CK. Combination of Lactobacillus acidophilus and Bifidobacterium animalis subsp. lactis shows a stronger anti-inflammatory effect than individual strains in HT-29 cells. Nutrients 2019; 11: 2678-86. |
| 26. | Sen T, Cawthon CR, Ihde BT, et al. Diet-driven microbiota dysbiosis is associated with vagal remodeling and obesity. Physiol Behav 2017; 180: 108-15. |
/
| 〈 |
|
〉 |